15.8 C
New York

[CytoReason in Calcalist] CytoReason raises $20 million from Pfizer for AI drug discovery and development platform


Pfizer will also have options to license the Israeli startup’s platform and disease models, and fund supplementary project support, in a deal potentially worth up to $110 million over the next five years

Read more here.

  • Coinsmart. Europe’s Best Bitcoin and Crypto Exchange.Click Here
  • Platoblockchain. Web3 Metaverse Intelligence. Knowledge Amplified. Access Here.
  • Source: https://blog.ourcrowd.com/cytoreason-raises-20-million-from-pfizer-for-ai-drug-discovery-and-development-platform/

Related articles


Recent articles